Novo Nordisk Discloses Clinical Trial Patient Data Breach
Pharmaceutical giant Novo Nordisk (maker of Ozempic and Wegovy) reported unauthorized access to internal IT systems where certain pseudonymized patient data from clinical trials was copied. Exposed information includes patient IDs, trial participation details, sex, year of birth, biomarkers, health data, and lifestyle factors. The company is investigating with external experts.
- patient-data
- health-information
- biomarkers
Pharmaceutical company Novo Nordisk has disclosed a security breach in which unauthorized actors accessed internal IT systems and copied pseudonymized patient data from clinical trials.
According to public reporting, the incident involved patient IDs, trial participation details, sex, year of birth, biomarkers, health information, and lifestyle factors. The company, known for medications including Ozempic and Wegovy, stated that the data was pseudonymized rather than fully anonymized. Novo Nordisk is working with external cybersecurity experts to investigate the breach, though the number of affected individuals remains unknown. Available reporting describes the event as unauthorized access rather than a ransomware attack, with no evidence yet published that the stolen information has been offered for sale on criminal forums.
Want the rest of this breakdown?
Sign up free to keep reading. Members get extended access, the weekly breach digest, and a complimentary Warden™ to see if their identity is exposed in the breaches we cover.
A breach leaks your credentials. Then hackers chain those credentials to your address, family, phone, and employer using public broker sites. We’re the only tool built around that chain.
⚠ Were you in this breach?
Free email scanner. We check your address against 15.4B+ leaked records in 15 seconds — then show you the $19 cleanup that removes you from the broker sites aggregating leaked data.
Check my email — free →